Ann Tsukamoto - StemCells Insider

StemCells -- USA Stock  

USD 11.52  0.00  0.00%

Executive VP of Scientific and Strategic Alliances

Dr. Ann Tsukamoto Ph.D. is Executive Vice President Scientific and Strategic Alliances of StemCells Inc. She was appointed Vice President Scientific Operations in June 1998 Vice President Research and Development in February 2002 Chief Operating Officer in November 2006 and Executive Vice President Research and Development in October 2008. In June 2013 Dr. Tsukamoto was appointed Executive Vice President Scientific and Strategic Alliances with responsibility for developing the Companys alliances with research institutions corporations government agencies and disease foundations. Dr. Tsukamoto is married to one of our outside directors.
Age: 61  EVP Since 2013      
510-456-4000  http://www.stemcellsinc.com

Management Efficiency

The company has return on total asset (ROA) of (92.96) % which means that it has lost $92.96 on every $100 spent on asset. This is way below average.
The company currently holds 2 M in liabilities with Debt to Equity (D/E) ratio of 1.6 which is about average as compared to similar companies. StemCells has Current Ratio of 0.6 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Entity Summary

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cellbased therapeutics and related technologies. StemCells (STEM) is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 74 people.

StemCells Leadership Team

Alan Trounson, Director
Irving Weissman, Director
John Schwartz, Chairman, Ph.D
Gregory Schiffman, President
Martin McGlynn, CEO
Ian Massey, President, Ph.D
Scott Greer, Director
Kenneth Stratton, Executive
Ricardo Levy, Director
Ann Tsukamoto, EVP
Eric Bjerkholt, Director

Stock Performance Indicators

Current Sentiment - STEM

StemCells Investor Sentiment
Most of Macroaxis users are at this time bullish on StemCells. What is your outlook on investing in StemCells? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip  Hide

Trending Equities

Currently Active Assets on Macroaxis
VMW   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 137.54
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 11.33
V   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 124.48
GM   
 NYQ 
Purchased over 70 shares of
few hours ago ago
Traded for 38.93
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 11.33
RKDA   
 NCM 
Purchased over 100 shares of
few hours ago ago
Traded for 25.72
Also please take a look at World Market Map. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.